Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Nifedipine for Vulvar Vestibulitis
NCT00496184Phase 3Completed
- Sponsor
- Galilee Medical Center
- Start
- Apr 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nifedipine in vulvodynia (3 arms), sponsored by Galilee Medical Center. Primary endpoint: Complete resolution of vestibulitis. Started Apr 2006; status: completed.
02
Drugs
nifedipine
03
Conditions
vulvodynia
Beyond the preview
Go deeper on NCT00496184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496184.